INHIBITION OF ANGIOGENESIS USING INTERLEUKIN-12

(19)

(11)

EP 0 809 511 A1

(12)

(43)	Date of publication:
	03.12.1997 Bulletin 1997/49

(21)	Application number: 96904008.0

(22)	Date of filing: 07.02.1996

(51)

International Patent Classification (IPC):

A61K 38/ 00^{( . )}
A61P 3/ 08^{( . )}
A61P 9/ 00^{( . )}
A61P 27/ 02^{( . )}
A61P 31/ 04^{( . )}
A61P 35/ 00^{( . )}

A61K 38/ 20^{( . )}
A61P 3/ 10^{( . )}
A61P 17/ 00^{( . )}
A61P 29/ 00^{( . )}
A61P 31/ 12^{( . )}

(86)	International application number:
	PCT/EP1996/000507

(87)	International publication number:
	WO 1996/025171 (22.08.1996 Gazette 1996/38)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

(30)

Priority:

16.02.1995 US 19950389382

(71)	Applicants:
	F. HOFFMANN-LA ROCHE AG 4070 Basel (CH) The Children's Medical Center Corporation Boston, Massachusetts 02115 (US)

(72)	Inventors:
	FOLKMAN, Moses, Judah Brookline, MA 02146 (US) TRUITT, Gary, Arthur Bloomfield, NJ 07003 (US) VOEST, Emile, Eugene NL-3769 BP Soesterberg (NL)

(74)	Representative: Witte, Hubert, Dr., et al
	124 Grenzacherstrasse 4070 Basel 4070 Basel (CH)

(54)	INHIBITION OF ANGIOGENESIS USING INTERLEUKIN-12